CD40LG and melanoma: Anti-CD40 11B6-CD40L-Melanoma gp100 Antigen Targeted to MDDCs Presents the Immune-Dominant Class I Peptide 209-217 More Efficiently Than Anti-CD40-Melanoma Antigen Fusions Without Linked CD40L